Keloids result from aberrant and overly exuberant wound healing and represent a significant cosmetic problem for affected individuals. We propose to expand currently a funded parent grant (ROIAR56672-01, Pharmacology of Dermal Fibrosis) to examine the pathophysiology of keloids in response to NOT-OD-09-058, NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications. Our current research is centered on determining the role of adenosine A2, receptors in the pathogenesis of fibrosis using mouse models and in vitro studies of normal dermal fibroblasts. We have previously demonstrated a significant role for these receptors in the pathogenesis of dermal and hepatic fibrosis and found evidence supporting multiple pathways of signal transduction. We propose here two complementary aims designed to study the pathogenesis of fibrosis in keloids. In the first aim we will explore the role of adenosine A2A receptors in the pathogenesis of keloids. Thus, our first aim is: To determine the number and function of adenosine receptors in keloidal fibroblasts. Using standard molecular and pharmacologic techniques we will study the effect of adenosine A2A and A2B receptor stimulation on signaling intermediates (cAMP), messages for stimulation of collagen production (flil levels in the nucleus and CTGF expression) and collagen production (mRNA and protein).
In Aim II we propose: To explore the hypothesis that adenosine or other growth factor receptors signal for aberrant protein expression in keloidal fibroblasts. Because it is possible that either aberrant adenosine signaling or aberrant signaling at growth factor receptors in keloidal fibroblasts (CTGF and TGFI3) may playa role in the pathogenesis of keloids we will study the effect of adenosine and growth factor stimulation on gene expression in normal and keloidal fibroblasts by microarray analysis of mRNA and smRNA. The results of the proposed experiments will shed light on aberrant signaling in keloidal fibroblasts and thus provide novel targets for therapeutic development in the treatment and prevention of keloids.

Public Health Relevance

Keloids are a form of overly exuberant wound healing that can lead to severe cosmetic and functional impairment. The pathophysiology of keloid formation is not well understood although there appears to be a genetic predilection for forming keloids. We propose to determine whether adenosine receptors, which we have found to playa central role in pathologic fibrosis, are involved in keloid formation and whether there is aberrant signaling for matrix production and proliferation due to adenosine or other receptor stimulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
3R01AR056672-01S1
Application #
7814358
Study Section
Special Emphasis Panel (ZRG1-MOSS-D (95))
Program Officer
Tseng, Hung H
Project Start
2009-09-23
Project End
2011-09-22
Budget Start
2009-09-23
Budget End
2011-09-22
Support Year
1
Fiscal Year
2009
Total Cost
$798,312
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Mediero, Aránzazu; Wilder, Tuere; Shah, Lopa et al. (2018) Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. FASEB J 32:3487-3501
Haskó, György; Antonioli, Luca; Cronstein, Bruce N (2018) Adenosine metabolism, immunity and joint health. Biochem Pharmacol 151:307-313
Yang, Lu; Fanok, Melania H; Mediero-Munoz, Aranzazu et al. (2018) Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis. Arthritis Rheumatol 70:855-867
Ishack, Stephanie; Mediero, Aranzazu; Wilder, Tuere et al. (2017) Bone regeneration in critical bone defects using three-dimensionally printed ?-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. J Biomed Mater Res B Appl Biomater 105:366-375
Feig, Jessica L; Mediero, Aranzazu; Corciulo, Carmen et al. (2017) The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. PLoS One 12:e0188135
Zhang, Jin; Corciulo, Carmen; Liu, Hailing et al. (2017) Adenosine A2a Receptor Blockade Diminishes Wnt/?-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis. Am J Pathol 187:1935-1944
Bradaschia-Correa, Vivian; Josephson, Anne M; Egol, Alexander J et al. (2017) Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice. Tissue Cell 49:545-551
Cronstein, Bruce N; Sitkovsky, Michail (2017) Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol 13:41-51
Corciulo, Carmen; Lendhey, Matin; Wilder, Tuere et al. (2017) Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat Commun 8:15019
Mediero, Aránzazu; Wilder, Tuere; Ramkhelawon, Bhama et al. (2016) Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis. FASEB J 30:3835-3844

Showing the most recent 10 out of 59 publications